“casimir-trials” Archives

in
Entry Author Date Location
Phil Sharp, CRISPR’ing the Heart & the Duchenne Data Gap on Oct. 17 09/11/19 Boston
FDA Rejects Sarepta’s Second Duchenne Drug, Citing Safety Concerns 08/19/19 Boston
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
Duchenne Advocates Start Casimir, Aiming to Capture Missing Data 07/26/19 Boston
Page 1 of 1